Photoblock
NDC Package 82160-221-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Photoblock is ® cream is used to provide maximum protection as well as youth and freshness. Marketed by Pella Pharmaceuticals Co. Ltd, this product is identified by NDC 82160-221 and is authorized under FDA application part352.

Identification & Billing

NDC Package Code
82160-221-01
Package Description
1 TUBE in 1 CARTON / 150 g in 1 TUBE
Product Code
11-Digit Billing Format
82160022101

Clinical Specifications

Proprietary Name
Photoblock
Dosage Form
-
Usage Information
Photoblock ® cream is used to provide maximum protection as well as youth and freshness. It contains Titanium Dioxide which is well known as a physical sunscreen that protects against UVB and sun burns, in addition to Avobenzone which provides complete protection against UVA.

Regulatory & Marketing

Labeler Name
Pella Pharmaceuticals Co. Ltd
FDA Application #
part352
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
06-17-2010
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82160-221-01 identifies a specific commercial package of 1 tube in 1 carton / 150 g in 1 tube of Photoblock, labeled by Pella Pharmaceuticals Co. Ltd. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pella Pharmaceuticals Co. Ltd on June 17, 2010. The current certification is valid through December 31, 2022.

How is this Pella Pharmaceuticals Co. Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82160022101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82160-221-01
11-Digit CMS (5-4-2)
82160-0221-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.